168 related articles for article (PubMed ID: 22026069)
21. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy.
Goldstein DP; Zanten-Przybysz IV; Bernstein MR; Berkowitz RS
J Reprod Med; 1998 Jan; 43(1):37-43. PubMed ID: 9475148
[TBL] [Abstract][Full Text] [Related]
22. [Histopathologic prognostic factors, serum markers and selected molecular biologic factors in ovarian carcinoma].
Spacek J; Jílek P; Petera J; Tesarík Z
Ceska Gynekol; 2002 Nov; 67(6):343-9. PubMed ID: 12661373
[TBL] [Abstract][Full Text] [Related]
23. [The development of gynaecological radiotherapy at the 1st department of obstetrics and gynaecology University of Vienna (a review of the past 25 years) (author's transl)].
Weghaupt K
Wien Klin Wochenschr; 1975 Jul; 87(14):436-44. PubMed ID: 769350
[TBL] [Abstract][Full Text] [Related]
24. The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.
Singh N; Gilks CB
Histopathology; 2017 Jan; 70(1):56-69. PubMed ID: 27960241
[TBL] [Abstract][Full Text] [Related]
25. Pattern of gynaecological malignancies at the University of Ilorin Teaching Hospital, Ilorin, Nigeria.
Ibrahim HM; Ijaiya MA
J Obstet Gynaecol; 2013 Feb; 33(2):194-6. PubMed ID: 23445148
[TBL] [Abstract][Full Text] [Related]
26. Second primitive malignant tumour in patients with gynaecological cancer.
Nunes F; Saraiva J; Francisca A; Botica MJ; Diniz Mdo C; Cabral I
Eur J Gynaecol Oncol; 1997; 18(6):488-91. PubMed ID: 9443017
[TBL] [Abstract][Full Text] [Related]
27. Treatment of gestational trophoblastic neoplasia according to the FIGO 2000 staging and scoring system: a 20 years' experience.
Wang KL; Yang YC; Wang TY; Cheng-Yen Lai J; Chen TC; Chang CL
Acta Obstet Gynecol Scand; 2009; 88(2):204-8. PubMed ID: 19031297
[TBL] [Abstract][Full Text] [Related]
28. [Ultrasonic staging cervical cancer -a proposal for the standard procedure].
Weinberger V; Dvořák M; Haaková L; Hašlík L; Herboltová P; Chaloupková B; Kožnarová J; Kubešová B; Lukáčová I; Marek R; Neumannová H; Peschout R; Přibyl V; Sedláková I; Smažinka M; Svobodová P; Vančo M; Vlasák P; Fischerová D; Zikán M; Gynecological Oncology Center Masaryk University and General Faculty Hospital Brno ; Gynecological Oncology Center Charles University Prague Czech Republic
Ceska Gynekol; 2014 Dec; 79(6):447-55. PubMed ID: 25585553
[TBL] [Abstract][Full Text] [Related]
29. [Gynaecological and breast cancers at the Dakar Cancer Institute].
Dem A; Traoré B; Dieng MM; Diop PS; Ouajdi T; Lalami MT; Diop M; Dangou JM; Touré P
Sante; 2008; 18(1):25-9. PubMed ID: 18684687
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications.
El-Ghobashy AE; Saidi SA
Eur J Surg Oncol; 2009 Jul; 35(7):675-85. PubMed ID: 18980825
[TBL] [Abstract][Full Text] [Related]
31. [News in histopathological diagnostics of precancerous lesions and tumors of the female genital tract].
Dundr P; Němejcová K
Ceska Gynekol; 2015 Mar; 80(2):93-6. PubMed ID: 25944598
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic immunohistochemistry in gynaecological neoplasia: a brief survey of the most common scenarios.
Kuhn E; Ayhan A
J Clin Pathol; 2018 Feb; 71(2):98-109. PubMed ID: 29183921
[TBL] [Abstract][Full Text] [Related]
33. [Da vinci robotic surgery in gynaecological oncology: a critical interim appraisal].
Bartos P; Struppl D; Trhlík M; Czudek S; Skrovina M; Adamcík L; Soumarová R
Ceska Gynekol; 2007 Oct; 72(5):354-9. PubMed ID: 18175521
[TBL] [Abstract][Full Text] [Related]
34. [Importance of clinical prognostic factors in the treatment of ovarian carcinoma].
Spacek J; Petera J; Tesarík Z
Ceska Gynekol; 2002 Sep; 67(5):280-5. PubMed ID: 12434665
[TBL] [Abstract][Full Text] [Related]
35. Does debulking of enlarged positive lymph nodes improve survival in different gynaecological cancers?
Somashekhar SP
Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):870-83. PubMed ID: 26043964
[TBL] [Abstract][Full Text] [Related]
36. The revised FIGO staging system for uterine malignancies: implications for MR imaging.
Freeman SJ; Aly AM; Kataoka MY; Addley HC; Reinhold C; Sala E
Radiographics; 2012 Oct; 32(6):1805-27. PubMed ID: 23065170
[TBL] [Abstract][Full Text] [Related]
37. Restaging in gynaecological cancers.
Ayhan A; Celik H; Coskun F; Baykal C; Salman MC; Aksan G
Eur J Gynaecol Oncol; 2005; 26(1):25-30. PubMed ID: 15754995
[TBL] [Abstract][Full Text] [Related]
38. Problematic issues in the staging of endometrial, cervical and vulval carcinomas.
Hirschowitz L; Nucci M; Zaino RJ
Histopathology; 2013 Jan; 62(1):176-202. PubMed ID: 23240675
[TBL] [Abstract][Full Text] [Related]
39. [Pathological aspects of gynecological malignancies--early stage cancers and borderline lesions].
Sakamoto A; Yoshikawa H
Gan No Rinsho; 1990 Aug; 36(10):1083-8. PubMed ID: 2214143
[TBL] [Abstract][Full Text] [Related]
40. [Synechia vulvae infantum--incidence on Department of Obstetric/Gynaecology, Teaching Hospital Na Bulovce, the First Medical Faculty of Charles University in Prague, Czech Republic from 2001 through 2005].
Jaresová V; Hrochová V; Sottner O; Halaska M
Ceska Gynekol; 2007 Apr; 72(2):131-5. PubMed ID: 17639736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
